
Expression of the ganglioside GD2 in SH-SY5Y ... - ResearchGate
Compared with GD2 levels in untreated SH-SY5Y cells, levels of GD2 in SH-SY5Y cells increased 2.5-fold in response to fenretinide under the same conditions used for the GD3 experiments...
Preclinical assessment of the efficacy and specificity of GD2-B7H3 ...
2021年1月21日 · Antibodies directed against disialoganglioside (GD2), a TAA found on NBLs, melanomas, and sarcomas, are routinely used in upfront and relapse NBL therapies and have improved...
Dual-targeting CAR-T cells with optimal co-stimulation and ... - Nature
2021年9月23日 · Here we show that CAR-T cells targeting simultaneously two tumor-associated antigens and providing trans-acting CD28 and 4-1BB co-stimulation, while sharing the same CD3ζ-chain cause rapid...
A novel anti-GD2/4-1BB chimeric antigen receptor triggers …
2015年9月9日 · We found a significant IFNγ release by GD2 CAR T cells over 48-hour cocultures with SH-SY5Y. In addition, we observed that GD2 CAR T cell action was associated with a dramatic release of a potent death ligand, namely TRAIL.
Transition to a mesenchymal state in neuroblastoma confers
2022年7月11日 · Here, we show that reduced GD2 expression was significantly correlated with the mesenchymal cell state in neuroblastoma and that a forced adrenergic-to-mesenchymal transition (AMT) conferred...
High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in …
One possible explanation for our findings is that a subset of SY5Y cells may express a level of GD2 just below the threshold antigen density required to trigger killing by the “wild-type” GD2 CAR-engineered T cells. SY5Y exhibits a fairly broad expression pattern spanning greater than 2 logs as measured by flow cytometry (see Fig. 3D ...
Anti-GD2 synergizes with CD47 blockade to mediate tumor …
In this study, we establish potent synergy for the combination of anti-GD2 and anti-CD47 in syngeneic and xenograft mouse models of neuroblastoma, where the combination eradicates tumors, as well as osteosarcoma and small-cell lung cancer, where the combination significantly reduces tumor burden and extends survival.
Frontiers | Transition to a mesenchymal state in neuroblastoma …
2024年4月25日 · The adrenergic cell line SH-SY5Y and its GD2 silenced counterpart SH-SY5Y/GD2 − were employed as controls of expression. Results were expressed as means ± SEM ( n = 3). Subsequently, we investigated the expression of GD3 (GD3S, ST8SIA1) and GD2 (GD2S, B4GALNT1) synthases that are involved in GD2 expression ( 16 ).
联合用药让细胞变身!或可改善晚期神经母细胞瘤患者的预后
2022年7月29日 · 将mes样sh-ep细胞系(gd2低表)与adrn样sh-sy5y细胞系(gd2高表)分别进行抗gd2免疫治疗细胞模型实验,结果显示sh-sy5y细胞被巨噬细胞吞噬及nk介导的肿瘤细胞杀伤作用显著高于sh-ep细胞系,表明在神经母细胞瘤中,细胞状态与gd2的表达和抗gd2治疗的反应有关。
Altered ganglioside expression by SH-SY5Y cells upon retinoic …
1994年4月14日 · SH-SY5Y cells were found to express at least 12 different gangliosides. RA-induced neuronal differentiation led to a decrease in the content of GM2, GD3, and GD2 and to a 3-7 fold increased concentration of the ganglio-tetraosyl gangliosides GM1, …